United States' qualifying conditions compared to evidence of the 2017 National Academy of Sciences Report
EL Stains, AL Kennalley, M Tian, KF Boehnke… - MedRxiv, 2023 - medrxiv.org
Abstract Objective To compare the 2017 National Academies of Sciences, Engineering, and
Medicine (NAS) report to state medical cannabis (MC) laws defining approved qualifying …
Medicine (NAS) report to state medical cannabis (MC) laws defining approved qualifying …
Cannabis Hyperemesis Syndrome: What Do We Know?
D Shine, A Goodin - Medical Cannabis and Cannabinoids, 2024 - karger.com
A form of hyperemesis known as cannabis hyperemesis syndrome (CHS) has gained
attention as a potential cannabis safety concern. CHS was first described as cyclical …
attention as a potential cannabis safety concern. CHS was first described as cyclical …
Cannabinoid Hyperemesis Syndrome: What Do We Know?
D Shine, A Goodin - 2024 - karger.com
Cannabinoid Hyperemesis Syndrome: What Do We Know? Page 1 1 Med Cannabis
Cannabinoids , DOI: 10.1159/000539182 Received: April 22, 2024 Accepted: April 28, 2024 …
Cannabinoids , DOI: 10.1159/000539182 Received: April 22, 2024 Accepted: April 28, 2024 …
[HTML][HTML] Cannabis Hyperemesis Syndrome in a Young Patient: A Case Report and Literature Review
N Khalid, M Abdullah, M Khalil, MA Afzal, M Hindawi - Cureus, 2023 - ncbi.nlm.nih.gov
Cannabis hyperemesis syndrome (CHS) is a condition characterized by recurrent episodes
of severe vomiting, abdominal pain, and intractable nausea in chronic cannabis users. With …
of severe vomiting, abdominal pain, and intractable nausea in chronic cannabis users. With …